The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation by Jobanputra, P, Barton, P, Bryan, S, Burls, A

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation. by Jobanputra, P, Barton, P, Bryan, S, Burls, A

Co-ordination of mechanical and engineering services / by 416983 Barton, P. K., Monaghan, T. J., Spiers, G. S.

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis by Clark, W, Jobanputra, P, Barton, P, Burls, A

Structures and magnetic properties of Mn and Co inorganic-organic frameworks with mixed linear dicarboxylate ligands by Saines, P, Barton, P, Jain, P, Cheetham, A

Predicting the life-time benefit of school-based smoking prevention programmes. by Jit, M, Aveyard, P, Barton, P, Meads, C

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis. by Clark, W, Jobanputra, P, Barton, P, Burls, A

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis. by Clark, W, Jobanputra, P, Barton, P, Burls, A

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis - Introduction by Barton, P, Jobanputra, P, Wilson, J, Bryan, S, Burls, A

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. by Barton, P, Jobanputra, P, Wilson, J, Bryan, S, Burls, A

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. by Barton, P, Jobanputra, P, Wilson, J, Bryan, S, Burls, A

An In-Depth Security Assessment of Maritime Container Terminal Software Systems by Joseph O. Eichenhofer, Elisa Heymann, Barton P. Miller, Arnold Kang

Get full text

MICE or NICE? An economic evaluation of clinical decision rules in the diagnosis of heart failure in primary care by Monahan, M, Barton, P, Taylor, C, Hobbs, R, REFER investigators

Modelling the appropriate provision of specialist clinics for Transient Ischaemic Attack by Barton, P, Sheppard, J, Penaloza, M, Jowett, S, McManus, R

Layered inorganic-organic frameworks based on the 2,2-dimethylsuccinate ligand: structural diversity and its effect on nanosheet exfoliation and magnetic properties. by Saines, P, Tan, J, Yeung, H, Barton, P, Cheetham, A

The importance of model structure in the cost-effectiveness analysis of primary care interventions for the management of hypertension by Peñaloza-Ramos, M, Jowett, S, Sutton, A, Mcmanus, R, Barton, P

Automating Risk Analysis of Software Design Models by Maxime Frydman, Guifré Ruiz, Elisa Heymann, Eduardo César, Barton P. Miller

Get full text

Measurement of the lifetime of the 3d2D5/2 state in 40Ca+ by Barton, P, Donald, C, Lucas, D, Stevens, D, Steane, A, Stacey, D

Optimisation of thrombolysis treatment: where to start? by Penaloza, M, Sheppard, J, Jowett, S, Barton, P, McManus, R, Clahrc, B

The REFER (REFer for EchocaRdiogram) study: a prospective validation and health economic analysis of a clinical decision rule, NT-proBNP or their combination in the diagnosis of he... by Taylor, C, Monahan, M, Roalfe, A, Barton, P, Iles, R, Hobbs, F